Diagnostic Development Articles & Analysis
25 articles found
Rigorous quality assurance protocols accompany ADCs development services. Each development phase undergoes rigorous testing to ensure top safety standards and build confidence among medical professionals and patients. Alfa Cytology stresses the need to develop therapies that demonstrate both efficacy and safety reliability. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. ...
Additionally, multiplex cytokine analysis is a valuable tool in vaccine development and drug discovery, providing real-time feedback on immune modulation. ...
In the rapidly evolving world of biotechnology, synthetic peptides have emerged as a pivotal component with wide-ranging applications in medical research, diagnostics, and therapeutic developments. These lab-created sequences of amino acids mimic naturally occurring peptides and are instrumental in advancing scientific discoveries and pharmaceutical innovations. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker development services to ...
Cytoskeleton Technologies ·High-Resolution Microscopy The development of advanced microscopy techniques, such as super-resolution microscopy (e.g., STORM, PALM), has drastically improved our ability to visualize the cytoskeleton. ...
They have the advantages of small size, high stability, and good penetration, and therefore have a wide range of application prospects in the fields of clinical treatment, diagnostic reagent development, etc.Characteristics of NanobodiesThe size of nanobodies usually ranges between 10-15kDa, which is only 1/10 of the size of regular antibodies. ...
Identification of key lipids and related enzymes can help to identify potential abnormalities in metabolic pathways or pathogenic mechanisms, and eventually develop effective diagnostic and therapeutic tools. Depending on the focus of the study, lipidomics can be applied to the following pharmaceutical research. ...
By profiling cytokine levels in cancer patients, researchers are able to identify patterns and correlations between cytokine levels and different stages of cancer development and progression. This information can then be used to develop new diagnostic and prognostic tools for cancer. ...
By profiling cytokine levels in cancer patients, researchers are able to identify patterns and correlations between cytokine levels and different stages of cancer development and progression. This information can then be used to develop new diagnostic and prognostic tools for cancer. ...
However, thanks to advancements in medical research and technology, significant progress has been made in the field of rare disease research, from developing accurate diagnostic tools to making effective small-molecule drugs. ...
Patients with Down syndrome show abnormal mental development and multiple organ malformations due to the presence of an extra chromosome 21. And the deletion or partial deletion of the X chromosome in females leads to Turner syndrome, which manifests abnormal development of reproductive organs. Abnormalities in Chromosome Structure Chromosomal structural ...
These diseases often come with significant challenges, including accurate diagnosis, availability of effective treatments, and limited resources for research and development. However, recent advancements in diagnostics technology hold promise for speeding up the field of rare disease therapies. ...
(IVS) provides innovative solutions to address the unmet technological needs in drug discovery and development for cardiovascular diseases and to predict adverse cardiotoxicity effects at the preclinical stage. ...
Clarice Reid, a true leader and advocate for those affected by sickle cell disease and BioMark Diagnostics Inc. a diagnostic company focused in developing better cancer care management solutions. ...
X-ZELL is collaborating with Singapore General Hospital (SGH) and the National University Hospital Singapore (NUH) to explore how X-ZELL single-cell diagnostics may aid in the early detection of clinically significant prostate cancer in whole blood. ...
Carrie Fisher was an American actress most well known for her role as Princess Leia in the Star Wars films (1977-1983 and 2015-2019). She was the daughter of singer Eddie Fisher and actress Debbie Reynolds. Carrie Fisher wrote the semi-autobiographical book Postcards from the Edge and the autobiography Wishful Drinking, which she turned into a one-woman stage show. She was open throughout her ...
How can BioSerenity help with the diagnosis of bipolar disorder? BioSerenity is developing remote diagnostics and physiologic signal recording to help in the detection of depression, bipolar disorder, and schizophrenia. Our goal is to provide a portable, ambulatory diagnostic device to allow screening and biomarker analysis of physiologic ...
The share price has fallen 12% to 220p Cancer diagnostics developer Oncimmune Holdings (LON: ONC) is delaying its 12-month results. ...
“Importantly, the detection of Neu5Gc in these cancer tissues is consistent with its role as a pan-cancer biomarker and further supports the development of INOVIQ’s SubB2M-based blood tests for breast and ovarian ...